Xu Wei, Banchereau Jacques
Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Roche Glycart AG , Schlieren , Switzerland.
The Jackson Laboratory, Institute for Genomic Medicine , Farmington, CT , USA.
Front Immunol. 2014 Jan 6;4:504. doi: 10.3389/fimmu.2013.00504.
The professional antigen presenting cells (APCs), including many subsets of dendritic cells and macrophages, not only mediate prompt but non-specific response against microbes, but also bridge the antigen-specific adaptive immune response through antigen presentation. In the latter, typically activated B cells acquire cognate signals from T helper cells in the germinal center of lymphoid follicles to differentiate into plasma cells (PCs), which generate protective antibodies. Recent advances have revealed that many APC subsets provide not only "signal 1" (the antigen), but also "signal 2" to directly instruct the differentiation process of PCs in a T-cell-independent manner. Herein, the different signals provided by these APC subsets to direct B cell proliferation, survival, class switching, and terminal differentiation are discussed. We furthermore propose that the next generation of vaccines for boosting antibody response could be designed by targeting APCs.
专业抗原呈递细胞(APC),包括多种树突状细胞和巨噬细胞亚群,不仅介导对微生物的快速但非特异性反应,还通过抗原呈递连接抗原特异性适应性免疫反应。在后一种情况下,通常被激活的B细胞从淋巴滤泡生发中心的辅助性T细胞获得同源信号,分化为浆细胞(PC),浆细胞产生保护性抗体。最近的进展表明,许多APC亚群不仅提供“信号1”(抗原),还提供“信号2”,以不依赖T细胞的方式直接指导PC的分化过程。本文讨论了这些APC亚群提供的不同信号,以指导B细胞增殖、存活、类别转换和终末分化。我们还提出,可以通过靶向APC来设计下一代增强抗体反应的疫苗。